Simulations Plus (SLP) Upgraded at BidaskClub

Simulations Plus (NASDAQ:SLP) was upgraded by equities research analysts at BidaskClub from a “sell” rating to a “hold” rating in a report released on Saturday.

A number of other equities research analysts have also issued reports on SLP. ValuEngine upgraded shares of Simulations Plus from a “hold” rating to a “buy” rating in a research note on Monday, April 2nd. Zacks Investment Research upgraded shares of Simulations Plus from a “hold” rating to a “buy” rating and set a $18.00 target price on the stock in a research note on Thursday, March 22nd.

How to Become a New Pot Stock Millionaire

Shares of SLP stock opened at $15.30 on Friday. Simulations Plus has a 12 month low of $10.55 and a 12 month high of $17.45. The firm has a market capitalization of $256.80, a price-to-earnings ratio of 45.00 and a beta of -0.56.

Simulations Plus (NASDAQ:SLP) last issued its quarterly earnings data on Tuesday, January 9th. The technology company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. Simulations Plus had a net margin of 23.78% and a return on equity of 24.56%. The firm had revenue of $7.07 million for the quarter, compared to analyst estimates of $6.57 million. equities analysts expect that Simulations Plus will post 0.4 earnings per share for the current fiscal year.

In other news, Chairman Walter S. Woltosz sold 18,500 shares of the company’s stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of $16.13, for a total value of $298,405.00. Following the sale, the chairman now owns 5,482,916 shares in the company, valued at approximately $88,439,435.08. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 33.45% of the company’s stock.

Institutional investors have recently modified their holdings of the company. Bank of Montreal Can acquired a new stake in shares of Simulations Plus in the 4th quarter valued at about $104,000. The Manufacturers Life Insurance Company grew its position in shares of Simulations Plus by 13.8% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 8,923 shares of the technology company’s stock valued at $110,000 after buying an additional 1,085 shares during the last quarter. Strs Ohio grew its position in shares of Simulations Plus by 196.9% during the 4th quarter. Strs Ohio now owns 9,500 shares of the technology company’s stock valued at $152,000 after buying an additional 6,300 shares during the last quarter. Algert Global LLC bought a new stake in shares of Simulations Plus during the 4th quarter valued at about $175,000. Finally, California State Teachers Retirement System bought a new stake in shares of Simulations Plus during the 2nd quarter valued at about $240,000. Institutional investors and hedge funds own 33.93% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Simulations Plus (SLP) Upgraded at BidaskClub” was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/04/07/simulations-plus-slp-upgraded-at-bidaskclub.html.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), and pharmacodynamics of drugs administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments, which measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments.

Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply